US 5,401,880 A · Chemical prevention or reversal of cataract by phase separation inhibitors

Abstract

The present invention relate to methods and pharmaceutical reagents for decreasing the phase separation temperature and inhibiting the formation of high molecular with aggregates in eye lenses, thereby inhibiting or reversing cataract formation.

Claims16

Dependent claims

A compound having the following formula:

##STR18##

Dependencies are inferred from the claim text.

Facts

Application

07/817,280Filed 2 Jan 1992 · continuation in part

Priority

4 Jun 1987

Granted

28 Mar 1995

Term ends

Not estimatedThe source records don’t support an estimate.

Classification7 codes

C07C 323/59
With amino groups bound to the carbon skeleton: with acylated amino groups bound to the carbon skeleton
C07C 255/24
Having cyano groups bound to acyclic carbon atoms: containing cyano groups and singly-bound nitrogen atoms, not being further bound to other…
C07C 323/25
Having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton: the carbon skeleton being acyclic and saturated
C07C 323/41
Y being a hydrogen or a carbon atom: y being a hydrogen or an acyclic carbon atom

Family

Serial58,140Parent of this continuation-in-part · filed 4 Jun 1987

Serial198,850Parent of this continuation-in-part · filed 26 May 1988

Serial451,955Parent of this continuation-in-part · filed 15 Dec 1989

Serial633,482Parent of this continuation-in-part · filed 27 Dec 1990

Serial725,045Parent of this continuation-in-part · filed 3 Jul 1991

US 5,401,880 AThis patent

From the US filing history. Foreign family members aren’t listed.

Chemical prevention or reversal of cataract by phase separation inhibitors

Life of this patent

Abstract

Claims16

Chemical prevention or reversal of cataract by phase separation inhibitors

Life of this patent

Abstract

Claims16